Compare AMRX & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | HCC |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2018 | 2017 |
| Metric | AMRX | HCC |
|---|---|---|
| Price | $18.05 | $79.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $15.60 | ★ $95.29 |
| AVG Volume (30 Days) | ★ 2.1M | 620.3K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.19 | ★ 1.37 |
| Revenue | N/A | ★ $1,310,043,000.00 |
| Revenue This Year | $4.48 | $59.95 |
| Revenue Next Year | $7.13 | $8.77 |
| P/E Ratio | $92.18 | ★ $57.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.67 | $49.07 |
| 52 Week High | $18.39 | $110.39 |
| Indicator | AMRX | HCC |
|---|---|---|
| Relative Strength Index (RSI) | 67.85 | 41.64 |
| Support Level | $12.46 | $77.26 |
| Resistance Level | N/A | $85.21 |
| Average True Range (ATR) | 0.59 | 2.84 |
| MACD | -0.05 | 0.28 |
| Stochastic Oscillator | 80.15 | 45.30 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Warrior Met Coal Inc produces and exports met or steelmaking coal, which is used as a component for steel production by metal manufacturers in Europe, South America, and Asia. The company is involved in longwall mining operations in its underground mines based in Alabama, Mine No. 4, Mine No. 7, and Blue Creek. Additionally, its natural gas operations remove and sell natural gas from owned and leased coal seams by reducing natural gas levels in its mines. The company generates revenue mainly through the production of steelmaking coal for sale to the steel industry. Geographically, the firm generates maximum revenue from its customers in Asia, followed by Europe, South America, and the United States.